The ascent of mouse: advances in modelling human depression and anxiety.

PubWeight™: 3.80‹?› | Rank: Top 1%

🔗 View Article (PMID 16138108)

Published in Nat Rev Drug Discov on September 01, 2005

Authors

John F Cryan1, Andrew Holmes

Author Affiliations

1: Neuroscience Research, Novartis Institutes for BioMedical Research, Basel CH 4055, Switzerland. johncryan@hotmail.com

Articles citing this

(truncated to the top 100)

Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry (2010) 6.15

Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J Neurosci (2008) 2.87

Heteroplasmy of mouse mtDNA is genetically unstable and results in altered behavior and cognition. Cell (2012) 2.81

Stress-induced prefrontal reorganization and executive dysfunction in rodents. Neurosci Biobehav Rev (2008) 2.33

Aberrant light directly impairs mood and learning through melanopsin-expressing neurons. Nature (2012) 2.26

Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry (2011) 2.11

Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity. Pain (2011) 2.01

Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci Biobehav Rev (2008) 1.65

Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry (2012) 1.63

Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice. Neuropharmacology (2007) 1.63

Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc (2012) 1.59

Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann N Y Acad Sci (2009) 1.59

A safe lithium mimetic for bipolar disorder. Nat Commun (2013) 1.51

Zebrafish models for translational neuroscience research: from tank to bedside. Trends Neurosci (2014) 1.51

Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. J Neurosci (2010) 1.49

Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cereb Cortex (2009) 1.48

Adaptive learning can result in a failure to profit from good conditions: implications for understanding depression. Evol Med Public Health (2015) 1.45

Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology (2008) 1.42

Feasibility of focal cerebral ischemia and reperfusion surgery combined with chronic unpredictable mild stress to simulate the post-stroke depressive state in rats. Behav Brain Funct (2015) 1.39

Ontogeny of fear-, anxiety- and depression-related behavior across adolescence in C57BL/6J mice. Behav Brain Res (2006) 1.37

The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? Neuropharmacology (2011) 1.36

An investigation of the behavioral actions of ethanol across adolescence in mice. Psychopharmacology (Berl) (2007) 1.36

Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol Psychiatry (2008) 1.36

Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior. Proc Natl Acad Sci U S A (2012) 1.33

Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci U S A (2008) 1.29

Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior. J Neurosci (2009) 1.29

50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov (2013) 1.28

Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models. Mol Psychiatry (2010) 1.28

Ethanol-related behaviors in mice lacking the NMDA receptor NR2A subunit. Psychopharmacology (Berl) (2006) 1.28

Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin. Transl Psychiatry (2012) 1.26

The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br J Pharmacol (2011) 1.25

Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain (2007) 1.25

Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain. Neuropsychopharmacology (2007) 1.25

Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain (2007) 1.21

The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learning. Biol Psychiatry (2007) 1.20

The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol Psychiatry (2008) 1.19

RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects. Proc Natl Acad Sci U S A (2010) 1.19

Aggression and anxiety: social context and neurobiological links. Front Behav Neurosci (2010) 1.18

Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology (Berl) (2008) 1.18

The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl) (2009) 1.17

Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology (Berl) (2010) 1.17

Impaired Pavlovian fear extinction is a common phenotype across genetic lineages of the 129 inbred mouse strain. Genes Brain Behav (2009) 1.16

Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol (2010) 1.15

The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology (Berl) (2007) 1.14

Activin in the brain modulates anxiety-related behavior and adult neurogenesis. PLoS One (2008) 1.14

Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience (2006) 1.14

Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biol Psychiatry (2010) 1.14

Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement. Neurosci Biobehav Rev (2007) 1.13

The behavioral actions of lithium in rodent models: leads to develop novel therapeutics. Neurosci Biobehav Rev (2007) 1.12

Molecular and genetic substrates linking stress and addiction. Brain Res (2009) 1.11

Phenotypic characterization of a genetically diverse panel of mice for behavioral despair and anxiety. PLoS One (2010) 1.10

Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology (2007) 1.08

Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus. Br J Pharmacol (2012) 1.08

Evaluation of reward processes in an animal model of depression. Psychopharmacology (Berl) (2006) 1.07

Translational animal models of autism and neurodevelopmental disorders. Dialogues Clin Neurosci (2012) 1.06

Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. Pharmacol Ther (2010) 1.05

Update in the methodology of the chronic stress paradigm: internal control matters. Behav Brain Funct (2011) 1.05

Resolving the neural circuits of anxiety. Nat Neurosci (2015) 1.04

Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice. PLoS One (2013) 1.04

Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol Motil (2013) 1.04

Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology (Berl) (2008) 1.04

Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology (2011) 1.03

Social isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stress. PLoS One (2011) 1.03

Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci (2010) 1.02

Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests. Psychopharmacology (Berl) (2010) 1.01

Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. J Neurochem (2009) 1.01

Genetic relationship between anxiety-related and fear-related behaviors in BXD recombinant inbred mice. Behav Pharmacol (2009) 1.01

Increased fear- and stress-related anxiety-like behavior in mice lacking tuberoinfundibular peptide of 39 residues. Genes Brain Behav (2008) 1.00

Evaluation of social and physical enrichment in modulation of behavioural phenotype in C57BL/6J female mice. PLoS One (2011) 1.00

Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings. Br J Pharmacol (2012) 1.00

Pharmacological enhancement of fear reduction: preclinical models. Br J Pharmacol (2011) 0.99

Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance- and depression-related behaviour. Br J Anaesth (2007) 0.99

Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety. Psychopharmacology (Berl) (2006) 0.99

Reward-related behavioral paradigms for addiction research in the mouse: performance of common inbred strains. PLoS One (2011) 0.99

Neuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disorders. Front Neurosci (2014) 0.98

Unstable maternal environment, separation anxiety, and heightened CO2 sensitivity induced by gene-by-environment interplay. PLoS One (2011) 0.97

Consilient research approaches in studying gene x environment interactions in alcohol research. Addict Biol (2010) 0.96

Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience (2008) 0.95

Reverse translational strategies for developing animal models of bipolar disorder. Dis Model Mech (2009) 0.94

Modelling cognitive affective biases in major depressive disorder using rodents. Br J Pharmacol (2014) 0.94

A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology (Berl) (2007) 0.94

Vulnerability to lasting anxiogenic effects of brief exposure to predator stimuli: sex, serotonin and other factors-relevance to PTSD. Neurosci Biobehav Rev (2008) 0.94

Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity. Philos Trans R Soc Lond B Biol Sci (2013) 0.94

Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiol Dis (2010) 0.94

Optogenetic insights on the relationship between anxiety-related behaviors and social deficits. Front Behav Neurosci (2014) 0.94

Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling. J Pharmacol Exp Ther (2009) 0.94

Mouse models of autism: testing hypotheses about molecular mechanisms. Curr Top Behav Neurosci (2011) 0.93

The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. Front Behav Neurosci (2011) 0.93

A translational rodent assay of affective biases in depression and antidepressant therapy. Neuropsychopharmacology (2013) 0.92

Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice. Neuropsychopharmacology (2013) 0.92

Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Struct Funct (2013) 0.92

Interdisciplinary perspectives on the development, integration, and application of cognitive ontologies. Front Neuroinform (2014) 0.92

The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy. Br J Pharmacol (2007) 0.92

Translational research in bipolar disorder: emerging insights from genetically based models. Mol Psychiatry (2010) 0.91

Interval timing accuracy and scalar timing in C57BL/6 mice. Behav Neurosci (2009) 0.90

Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment. BMC Genomics (2013) 0.90

Leptin-deficient mice retain normal appetitive spatial learning yet exhibit marked increases in anxiety-related behaviours. Psychopharmacology (Berl) (2010) 0.90

Resistance to early-life stress in mice: effects of genetic background and stress duration. Front Behav Neurosci (2011) 0.90

Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice. Neuropharmacology (2011) 0.89

Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. Int J Neuropsychopharmacol (2009) 0.89

Articles by these authors

(truncated to the top 100)

Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry (2010) 6.15

Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci (2006) 3.92

Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J Neurosci (2008) 2.87

Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J Neurosci (2006) 2.68

Why New Zealand must rapidly halve its greenhouse gas emissions. N Z Med J (2009) 2.67

The role of inositol 1,4,5-trisphosphate receptors in Ca(2+) signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol (2002) 2.05

Effects of repeated maternal separation on anxiety- and depression-related phenotypes in different mouse strains. Neurosci Biobehav Rev (2006) 2.00

Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci (2010) 1.99

The evolution of class 1 integrons and the rise of antibiotic resistance. J Bacteriol (2008) 1.83

Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology (2006) 1.58

How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology (2008) 1.56

Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol (2006) 1.52

Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. J Neurosci (2010) 1.49

Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cereb Cortex (2009) 1.48

Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit. Learn Mem (2008) 1.46

Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia. Neuropsychopharmacology (2008) 1.43

Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning. Neuropsychopharmacology (2008) 1.43

Ontogeny of fear-, anxiety- and depression-related behavior across adolescence in C57BL/6J mice. Behav Brain Res (2006) 1.37

An investigation of the behavioral actions of ethanol across adolescence in mice. Psychopharmacology (Berl) (2007) 1.36

Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am J Psychiatry (2010) 1.34

The touchscreen operant platform for testing learning and memory in rats and mice. Nat Protoc (2013) 1.31

Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF. Nat Neurosci (2011) 1.30

Chronic alcohol produces neuroadaptations to prime dorsal striatal learning. Proc Natl Acad Sci U S A (2013) 1.30

Genetic and dopaminergic modulation of reversal learning in a touchscreen-based operant procedure for mice. Behav Brain Res (2006) 1.29

50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov (2013) 1.28

Ethanol-related behaviors in mice lacking the NMDA receptor NR2A subunit. Psychopharmacology (Berl) (2006) 1.28

Amygdala FAAH and anandamide: mediating protection and recovery from stress. Trends Pharmacol Sci (2013) 1.27

Rescue of impaired fear extinction and normalization of cortico-amygdala circuit dysfunction in a genetic mouse model by dietary zinc restriction. J Neurosci (2010) 1.25

Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain. Neuropsychopharmacology (2007) 1.25

Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. J Neurosci (2006) 1.21

The touchscreen operant platform for assessing executive function in rats and mice. Nat Protoc (2013) 1.21

Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology (2005) 1.20

Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology (Berl) (2008) 1.18

Ethanol-related behaviors in serotonin transporter knockout mice. Alcohol Clin Exp Res (2006) 1.18

The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology (Berl) (2007) 1.14

Effects of repeated maternal separation on prepulse inhibition of startle across inbred mouse strains. Genes Brain Behav (2006) 1.13

Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory. Proc Natl Acad Sci U S A (2012) 1.12

Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes. Neuropsychopharmacology (2012) 1.11

GluN2B in corticostriatal circuits governs choice learning and choice shifting. Nat Neurosci (2013) 1.10

Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav Genet (2007) 1.10

Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor. Eur J Neurosci (2004) 1.10

Platelets and cardiovascular disease. Eur J Cardiovasc Nurs (2002) 1.10

Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cell Mol Neurobiol (2006) 1.09

Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc Natl Acad Sci U S A (2005) 1.08

RNA sequencing reveals differential expression of mitochondrial and oxidation reduction genes in the long-lived naked mole-rat when compared to mice. PLoS One (2011) 1.08

Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res (2006) 1.05

Functional roles of NMDA receptor NR2A and NR2B subunits in the acute intoxicating effects of ethanol in mice. Synapse (2005) 1.04

Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization. Psychopharmacology (Berl) (2008) 1.04

Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist. Biol Psychiatry (2008) 1.04

Chronic swim stress alters sensitivity to acute behavioral effects of ethanol in mice. Physiol Behav (2007) 1.03

Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci (2010) 1.02

Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder? Neuropharmacology (2011) 1.02

Genetic relationship between anxiety-related and fear-related behaviors in BXD recombinant inbred mice. Behav Pharmacol (2009) 1.01

Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests. Psychopharmacology (Berl) (2010) 1.01

The acute intoxicating effects of ethanol are not dependent on the vasopressin 1a or 1b receptors. Neuropeptides (2006) 1.00

Enhanced extinction of aversive memories by high-frequency stimulation of the rat infralimbic cortex. PLoS One (2012) 1.00

Genetic and structural analysis of the basolateral amygdala complex in BXD recombinant inbred mice. Behav Genet (2006) 0.99

Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav (2005) 0.99

Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells. Circ Res (2005) 0.99

Reward-related behavioral paradigms for addiction research in the mouse: performance of common inbred strains. PLoS One (2011) 0.99

Vertical instability in spondylolisthesis: a traction radiographic assessment technique and the principle of management. Spine (Phila Pa 1976) (2003) 0.98

Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model. Neuropharmacology (2012) 0.98

Effects of Subchronic Phencyclidine (PCP) Treatment on Social Behaviors, and Operant Discrimination and Reversal Learning in C57BL/6J Mice. Front Behav Neurosci (2009) 0.97

Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res (2005) 0.97

Role of major NMDA or AMPA receptor subunits in MK-801 potentiation of ethanol intoxication. Alcohol Clin Exp Res (2008) 0.95

Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress. Neuropsychopharmacology (2008) 0.95

A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology (Berl) (2007) 0.94

Vulnerability to lasting anxiogenic effects of brief exposure to predator stimuli: sex, serotonin and other factors-relevance to PTSD. Neurosci Biobehav Rev (2008) 0.94

Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiol Dis (2010) 0.94

Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics. Neuroimage (2004) 0.93

Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia. Front Neurosci (2010) 0.93

A novel role for PSD-95 in mediating ethanol intoxication, drinking and place preference. Addict Biol (2011) 0.93

Diabetes impairs cortical plasticity and functional recovery following ischemic stroke. J Neurosci (2012) 0.93

Medial hypothalamic 5-hydroxytryptamine (5-HT)1A receptors regulate neuroendocrine responses to stress and exploratory locomotor activity: application of recombinant adenovirus containing 5-HT1A sequences. J Neurosci (2004) 0.93

Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice. Learn Mem (2002) 0.91

Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout mice. Neuropeptides (2005) 0.90

Yohimbine impairs extinction of cocaine-conditioned place preference in an alpha2-adrenergic receptor independent process. Learn Mem (2008) 0.90

Fear extinction deficits following acute stress associate with increased spine density and dendritic retraction in basolateral amygdala neurons. Eur J Neurosci (2013) 0.89

All (C57BL/6) Mice are not Created Equal. Front Neurosci (2011) 0.89

Tumor necrosis factor-like weak inducer of apoptosis attenuates the action of insulin in hepatocytes. Endocrinology (2008) 0.89

Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice. Neuropharmacology (2011) 0.89

Fear memory impairing effects of systemic treatment with the NMDA NR2B subunit antagonist, Ro 25-6981, in mice: attenuation with ageing. Pharmacol Biochem Behav (2008) 0.88

Effects of chronic swim stress on EtOH-related behaviors in C57BL/6J, DBA/2J and BALB/cByJ mice. Behav Brain Res (2007) 0.88

Impaired associative fear learning in mice with complete loss or haploinsufficiency of AMPA GluR1 receptors. Front Behav Neurosci (2007) 0.87

Chronic alcohol alters rewarded behaviors and striatal plasticity. Addict Biol (2014) 0.86

Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders. Br J Pharmacol (2014) 0.86

Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST. Neuropharmacology (2012) 0.86

Desipramine potentiation of the acute depressant effects of ethanol: modulation by alpha2-adrenoreceptors and stress. Neuropharmacology (2008) 0.85

Probing the modulation of acute ethanol intoxication by pharmacological manipulation of the NMDAR glycine co-agonist site. Alcohol Clin Exp Res (2012) 0.85

HIV-1 Env gp120 structural determinants for peptide triazole dual receptor site antagonism. Proteins (2012) 0.85

An unusual integron in Treponema denticola. Microbiology (2004) 0.84

Short-term and long-term effects of postnatal exposure to an adult male in C57BL/6J mice. Behav Brain Res (2007) 0.82

Genome-wide gene expression profiling in GluR1 knockout mice: key role of the calcium signaling pathway in glutamatergically mediated hippocampal transmission. Eur J Neurosci (2009) 0.82

Quantitative trait loci for sensitivity to ethanol intoxication in a C57BL/6J×129S1/SvImJ inbred mouse cross. Mamm Genome (2012) 0.81

Convergent effects of mouse Pet-1 deletion and human PET-1 variation on amygdala fear and threat processing. Exp Neurol (2013) 0.80

Restraint stress and exogenous corticosterone differentially alter sensitivity to the sedative-hypnotic effects of ethanol in inbred long-sleep and inbred short-sleep mice. Alcohol (2008) 0.80

The role of galanin in modulating stress-related neural pathways. Drug News Perspect (2006) 0.79

Tolerance to ethanol intoxication after chronic ethanol: role of GluN2A and PSD-95. Addict Biol (2014) 0.79

Stress-induced deficits in cognition and emotionality: a role of glutamate. Curr Top Behav Neurosci (2012) 0.78

Non-natural peptide triazole antagonists of HIV-1 envelope gp120. ChemMedChem (2012) 0.77